Waubant E - Search Results

1

Trial of Fingolimod versus Interferon Beta-1a in Pediatric Multiple Sclerosis.

Chitnis T, Arnold DL, Banwell B, Brück W, Ghezzi A, Giovannoni G, Greenberg B, Krupp L, Rostásy K, Tardieu M, Waubant E, Wolinsky JS, Bar-Or A, Stites T, Chen Y, Putzki N, Merschhemke M, Gärtner J; PARADIGMS Study Group. Chitnis T, et al. Among authors: waubant e. N Engl J Med. 2018 Sep 13;379(11):1017-1027. doi: 10.1056/NEJMoa1800149. N Engl J Med. 2018. PMID: 30207920 Free article. Clinical Trial.

2

[Effect of weekly intramuscular interferon beta-1a on MRI lesions in patients with relapsing multiple sclerosis].

Waubant E, Sloan R, Andersson PB, Goodkin D. Waubant E, et al. Rev Neurol (Paris). 1999;155 Suppl 2:S20-3. Rev Neurol (Paris). 1999. PMID: 10367321 Clinical Trial. French.

3

A pilot study of MRI activity before and during interferon beta-1a therapy.

Waubant E, Goodkin DE, Sloan R, Andersson PB. Waubant E, et al. Neurology. 1999 Sep 11;53(4):874-6. doi: 10.1212/wnl.53.4.874. Neurology. 1999. PMID: 10489060

4

A phase I trial of solubilized DR2:MBP84-102 (AG284) in multiple sclerosis.

Goodkin DE, Shulman M, Winkelhake J, Waubant E, Andersson P, Stewart T, Nelson S, Fischbein N, Coyle PK, Frohman E, Jacobs L, Holcenberg J, Lee M, Mocci S. Goodkin DE, et al. Among authors: waubant e. Neurology. 2000 Apr 11;54(7):1414-20. doi: 10.1212/wnl.54.7.1414. Neurology. 2000. PMID: 10751249 Clinical Trial.

5

Magnetization transfer ratio in new MS lesions before and during therapy with IFNbeta-1a.

Kita M, Goodkin DE, Bacchetti P, Waubant E, Nelson SJ, Majumdar S. Kita M, et al. Among authors: waubant e. Neurology. 2000 May 9;54(9):1741-5. doi: 10.1212/wnl.54.9.1741. Neurology. 2000. PMID: 10802778

6

Relationship between serum levels of IL-10, MRI activity and interferon beta-1a therapy in patients with relapsing remitting MS.

Waubant E, Gee L, Bacchetti P, Sloan R, Cotleur A, Rudick R, Goodkin D. Waubant E, et al. J Neuroimmunol. 2001 Jan 1;112(1-2):139-45. doi: 10.1016/s0165-5728(00)00355-6. J Neuroimmunol. 2001. PMID: 11108942

7

Interferon beta-1a in children with multiple sclerosis is well tolerated.

Waubant E, Hietpas J, Stewart T, Dyme Z, Herbert J, Lacy J, Miller C, Rensel M, Schwid S, Goodkin D. Waubant E, et al. Neuropediatrics. 2001 Aug;32(4):211-3. doi: 10.1055/s-2001-17370. Neuropediatrics. 2001. PMID: 11571702

8

Pediatric multiple sclerosis.

Chabas D, Green AJ, Waubant E. Chabas D, et al. Among authors: waubant e. NeuroRx. 2006 Apr;3(2):264-75. doi: 10.1016/j.nurx.2006.01.011. NeuroRx. 2006. PMID: 16554264 Free PMC article. Review.

9

Challenges in the classification of pediatric multiple sclerosis and future directions.

Belman AL, Chitnis T, Renoux C, Waubant E; International Pediatric MS Study Group. Belman AL, et al. Among authors: waubant e. Neurology. 2007 Apr 17;68(16 Suppl 2):S70-4. doi: 10.1212/01.wnl.0000259421.40556.76. Neurology. 2007. PMID: 17438242 Review.

10

Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study.

Banwell B, Krupp L, Kennedy J, Tellier R, Tenembaum S, Ness J, Belman A, Boiko A, Bykova O, Waubant E, Mah JK, Stoian C, Kremenchutzky M, Bardini MR, Ruggieri M, Rensel M, Hahn J, Weinstock-Guttman B, Yeh EA, Farrell K, Freedman M, Iivanainen M, Sevon M, Bhan V, Dilenge ME, Stephens D, Bar-Or A. Banwell B, et al. Among authors: waubant e. Lancet Neurol. 2007 Sep;6(9):773-81. doi: 10.1016/S1474-4422(07)70196-5. Lancet Neurol. 2007. PMID: 17689148

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

338 results

Search Page